SANOFI INDIA LIMITED (SANOFI) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

SANOFIUpdated 1 Sept 2026, 20:02

Sanofi India Limited

Market Cap

₹7,260Cr.

Current Price

₹3,155

High / Low

₹5,197/3,054

Stock P/E

21.2

ROE43.0%
ROCE57.5%
Book Value₹359
Face Value₹10.0
Dividend Yield2.38%

About

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryDec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Debtor Days212422292127191817174235
Inventory Days179173169151154127107110125202186127
Days Payable1228179119110100931051098915179
Cash Conversion Cycle781151126165543322331307783
Working Capital Days26979171835-8-20-1924177
ROCE %22%26%27%26%29%28%32%35%41%71%49%58%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 20:02


Designed & Shipped by Harshit Bansal